Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Celina May
Institutions:
University Children's Hospital Tübingen,
University of Tübingen
Observed institutions:
University Children's Hospital Tübingen,
Universitätsklinikum Würzburg,
University of Tübingen
ORCID:
0009-0006-0086-3983
Observed ORCID:
0009-0006-0086-3983
OpenAlex ID:
A5002883515
EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures
2022
·
Matthias Peindl
, Claudia Göttlich
, et al.
·
Cancers
·
25
PDF
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency
2026
·
Philip Bucher
, Nadine Brückner
, et al.
·
Nature Cancer
·
5
Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
·
Cancer Discovery
·
1
Supplementary Table S2 from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Supplementary Figures S1-9 from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Supplementary Table S3 from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Supplementary Table S4 from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Supplementary Table S1 from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Data from Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
Abstract C008: NFIL3 emerges as a driver of CAR T cell dysfunction from integrated in vivo/in vitro CRISPR screen
2026
·
Nayan Jain
, Yuzhe Shi
, et al.
·
Cancer Immunology Research
Abstract LB024: CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency
2025
·
Josef Leibold
, Philip Bucher
, et al.
·
Cancer Research
Show more works
View as search
Works count:
11
Citation count:
31
H-index:
2
I10-index:
1
Year
Topic
Type